<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36834952</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>10</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Insertion of an Amphipathic Linker in a Tetrapodal Tryptophan Derivative Leads to a Novel and Highly Potent Entry Inhibitor of Enterovirus A71 Clinical Isolates.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3539</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24043539</ELocationID><Abstract><AbstractText><b>AL-471</b>, the leading exponent of a class of potent HIV and enterovirus A71 (EV-A71) entry inhibitors discovered in our research group, contains four l-tryptophan (Trp) units bearing an aromatic isophthalic acid directly attached to the C2 position of each indole ring. Starting from <b>AL-471</b>, we (i) replaced l-Trp with d-Trp, (ii) inserted a flexible linker between C2 and the isophthalic acid, and (iii) substituted a nonaromatic carboxylic acid for the terminal isophthalic acid. Truncated analogues lacking the Trp motif were also synthesized. Our findings indicate that the antiviral activity seems to be largely independent of the stereochemistry (l- or d-) of the Trp fragment and also that both the Trp unit and the distal isophthalic moiety are essential for antiviral activity. The most potent derivative, <b>23</b> (<b>AL-534</b>), with the C2 shortest alkyl urea linkage (three methylenes), showed subnanomolar potency against different EV-71 clinical isolates. This finding was only observed before with the early dendrimer prototype <b>AL-385</b> (12 l-Trp units) but remained unprecedented for the reduced-size prototype <b>AL-471</b>. Molecular modeling showed the feasibility of high-affinity binding of the novel l-Trp-decorated branches of <b>23</b> (<b>AL-534</b>) to an alternative site on the VP1 protein that harbors significant sequence variation among EV-71 strains.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mart&#xed;-Mar&#xed;</LastName><ForeName>Olaia</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Instituto de Qu&#xed;mica M&#xe9;dica (IQM, CSIC), E-28006 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdelnabi</LastName><ForeName>Rana</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-9771-7312</Identifier><AffiliationInfo><Affiliation>Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Department of Microbiology and Immunology, University of Leuven, B-3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schols</LastName><ForeName>Dominique</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-3256-5850</Identifier><AffiliationInfo><Affiliation>Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Department of Microbiology and Immunology, University of Leuven, B-3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neyts</LastName><ForeName>Johan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-0033-7514</Identifier><AffiliationInfo><Affiliation>Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Department of Microbiology and Immunology, University of Leuven, B-3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camarasa</LastName><ForeName>Mar&#xed;a-Jos&#xe9;</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-4978-6468</Identifier><AffiliationInfo><Affiliation>Instituto de Qu&#xed;mica M&#xe9;dica (IQM, CSIC), E-28006 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gago</LastName><ForeName>Federico</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-3071-4878</Identifier><AffiliationInfo><Affiliation>Departamento de Ciencias Biom&#xe9;dicas y Unidad Asociada IQM-UAH, Universidad de Alcal&#xe1;, E-28805 Alcal&#xe1; de Henares, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>San-F&#xe9;lix</LastName><ForeName>Ana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4271-7598</Identifier><AffiliationInfo><Affiliation>Instituto de Qu&#xed;mica M&#xe9;dica (IQM, CSIC), E-28006 Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PID2019-104070RB-C21 and PID2019-104070RB-C22 [AEI/10.13039/501100011033</GrantID><Agency>Spanish MICINN</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>8DUH1N11BX</RegistryNumber><NameOfSubstance UI="D014364">Tryptophan</NameOfSubstance></Chemical><Chemical><RegistryNumber>121-91-5</RegistryNumber><NameOfSubstance UI="C059768">isophthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D023581">HIV Fusion Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014364" MajorTopicYN="N">Tryptophan</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D023581" MajorTopicYN="Y">HIV Fusion Inhibitors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EV71</Keyword><Keyword MajorTopicYN="N">HIV</Keyword><Keyword MajorTopicYN="N">SAR</Keyword><Keyword MajorTopicYN="N">antiviral agents</Keyword><Keyword MajorTopicYN="N">tryptophan</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>2</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36834952</ArticleId><ArticleId IdType="pmc">PMC9959982</ArticleId><ArticleId IdType="doi">10.3390/ijms24043539</ArticleId><ArticleId IdType="pii">ijms24043539</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>United Nations Programme on HIV/Aids  UNAIDS UNAIDS Data 2021. 2021.  [(accessed on 29 November 2021)]. pp. 4&#x2013;38. Available online:  https://www.unaids.org.</Citation></Reference><Reference><Citation>Mocroft A., Vella S., Benfield T.L., Chiesi A., Miller V., Gargalianos P., D&#x2019;Arminio Monforte A., Yust I., Bruun J.N., Phillips A.N., et al. Changing Patterns of Mortality across Europe in Patients Infected with HIV-1. Lancet. 1998;352:1725&#x2013;1730. doi: 10.1016/S0140-6736(98)03201-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(98)03201-2</ArticleId><ArticleId IdType="pubmed">9848347</ArticleId></ArticleIdList></Reference><Reference><Citation>Delaney K.M., Moorman A.C., Loveless M.O., F&#xfc;hrer J., Satten G.A. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection. HIV Outpatient Study Investigators. Respir. Care. 1998;43:544.</Citation><ArticleIdList><ArticleId IdType="pubmed">9516219</ArticleId></ArticleIdList></Reference><Reference><Citation>Montaner J.S.G., Montessori V., Harrigan R., O&#x2019;Shaughnessy M., Hogg R. Antiretroviral Therapy: &#x201c;The State of the Art&#x201d;. Biomed. Pharmacother. 1999;53:63&#x2013;72. doi: 10.1016/S0753-3322(99)80062-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0753-3322(99)80062-6</ArticleId><ArticleId IdType="pubmed">10337460</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva B.F., Peixoto G.M.L., da Luz S.R., de Moraes S.M.F., Peres S.B. Adverse Effects of Chronic Treatment with the Main Subclasses of Highly Active Antiretroviral Therapy: A Systematic Review. HIV Med. 2019;20:429&#x2013;438. doi: 10.1111/hiv.12733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hiv.12733</ArticleId><ArticleId IdType="pubmed">31006976</ArticleId></ArticleIdList></Reference><Reference><Citation>Horne R., Chapman S., Glendinning E., Date H.L., Guitart J., Cooper V. Mind Matters: Treatment Concerns Predict the Emergence of Antiretroviral Therapy Side Effects in People with HIV. AIDS Behav. 2019;23:489&#x2013;498. doi: 10.1007/s10461-018-2239-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10461-018-2239-6</ArticleId><ArticleId IdType="pmc">PMC6373523</ArticleId><ArticleId IdType="pubmed">30187235</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozano F., Domingo P. Antiretroviral Therapy for HIV Infection. Enferm. Infecc. Microbiol. Clin. 2011;29:455&#x2013;465. doi: 10.1016/j.eimc.2011.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eimc.2011.02.009</ArticleId><ArticleId IdType="pubmed">21489658</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan P., Pannecouque C., De Clercq E., Liu X. Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends. J. Med. Chem. 2016;59:2849&#x2013;2878. doi: 10.1021/acs.jmedchem.5b00497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.5b00497</ArticleId><ArticleId IdType="pubmed">26509831</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B. Molecular Mechanism of HIV-1 Entry. Trends Microbiol. 2019;27:878&#x2013;891. doi: 10.1016/j.tim.2019.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2019.06.002</ArticleId><ArticleId IdType="pmc">PMC6744290</ArticleId><ArticleId IdType="pubmed">31262533</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan D.C., Kim P.S. HIV Entry and Its Inhibition. Cell. 1998;93:681&#x2013;684. doi: 10.1016/S0092-8674(00)81430-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)81430-0</ArticleId><ArticleId IdType="pubmed">9630213</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon V., Fridkis-Hareli M., Munisamy S., Lee J., Anastasiades D., Stevceva L. The GP120 Molecule of HIV-1 and Its Interaction with T Cells. Curr. Med. Chem. 2010;17:741&#x2013;749. doi: 10.2174/092986710790514499.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/092986710790514499</ArticleId><ArticleId IdType="pubmed">20088758</ArticleId></ArticleIdList></Reference><Reference><Citation>Governa P., Manetti F. Recent Research Results Have Converted Gp120 Binders to a Therapeutic Option for the Treatment of HIV-1 Infection. A Medicinal Chemistry Point of View. Eur. J. Med. Chem. 2021;229:114078. doi: 10.1016/j.ejmech.2021.114078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2021.114078</ArticleId><ArticleId IdType="pubmed">34992041</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P.C. An Overview of the Evolution of Enterovirus 71 and Its Clinical and Public Health Significance. FEMS Microbiol. Rev. 2002;26:91&#x2013;107. doi: 10.1111/j.1574-6976.2002.tb00601.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2002.tb00601.x</ArticleId><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L.-Y., Huang L.-M., Gau S.S.-F., Wu Y.-Y., Hsia S.-H., Fan T.-Y., Lin K.-L., Huang Y.-C., Lu C.-Y., Lin T.-Y. Neurodevelopment and Cognition in Children after Enterovirus 71 Infection. N. Engl. J. Med. 2007;356:1226&#x2013;1234. doi: 10.1056/NEJMoa065954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa065954</ArticleId><ArticleId IdType="pubmed">17377160</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T., Lewthwaite P., Perera D., Cardosa M.J., McMinn P., Ooi M.H. Virology, Epidemiology, Pathogenesis, and Control of Enterovirus 71. Lancet Infect. Dis. 2010;10:778&#x2013;790. doi: 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang W.-C., Huang L.M., Cheng A.-L., Chang L.-Y. Atypical hand-foot-mouth disease in children: A hospital-based prospective cohort study. Virol. J. 2013;10:209. doi: 10.1186/1743-422X-10-209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-10-209</ArticleId><ArticleId IdType="pmc">PMC3717056</ArticleId><ArticleId IdType="pubmed">23800163</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J.Y., Kung Y.A., Shih S.R. Antivirals and Vaccines for Enterovirus A71. J. Biomed. Sci. 2019;26:65. doi: 10.1186/s12929-019-0560-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-019-0560-7</ArticleId><ArticleId IdType="pmc">PMC6720414</ArticleId><ArticleId IdType="pubmed">31481071</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M.-L., Shih S.-R., Tolbert B.S., Brewer G., Sobrino F. Enterovirus A71 Vaccines. Vaccines. 2021;9:199. doi: 10.3390/vaccines9030199.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9030199</ArticleId><ArticleId IdType="pmc">PMC7997495</ArticleId><ArticleId IdType="pubmed">33673595</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Hu Y., Zheng M. Enterovirus A71 Antivirals: Past, Present, and Future. Acta Pharm. Sin. B. 2021;12:1542&#x2013;1566. doi: 10.1016/j.apsb.2021.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2021.08.017</ArticleId><ArticleId IdType="pmc">PMC9279511</ArticleId><ArticleId IdType="pubmed">35847514</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivero-Buceta E., Doyag&#xfc;ez E.G., Colomer I., Quesada E., Mathys L., Noppen S., Liekens S., Camarasa M.J., P&#xe9;rez-P&#xe9;rez M.J., Balzarini J., et al. Tryptophan Dendrimers That Inhibit HIV Replication, Prevent Virus Entry and Bind to the HIV Envelope Glycoproteins Gp120 and Gp41. Eur. J. Med. Chem. 2015;106:34&#x2013;43. doi: 10.1016/j.ejmech.2015.10.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2015.10.031</ArticleId><ArticleId IdType="pubmed">26513643</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivero-Buceta E., Sun L., Mart&#xed;nez-Gualda B., Doyag&#xfc;ez E.G., Donckers K., Quesada E., Camarasa M.-J., Delang L., San-F&#xe9;lix A., Neyts J., et al. Optimization of a Class of Tryptophan Dendrimers That Inhibit HIV Replication Leads to a Selective, Specific, and Low-Nanomolar Inhibitor of Clinical Isolates of Enterovirus A71. Antimicrob. Agents Chemother. 2016;60:5064&#x2013;5067. doi: 10.1128/AAC.00626-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00626-16</ArticleId><ArticleId IdType="pmc">PMC4958208</ArticleId><ArticleId IdType="pubmed">27246775</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Gualda B., Sun L., Mart&#xed;-Mar&#xed; O., Noppen S., Abdelnabi R., Bator C.M., Quesada E., Delang L., Mirabelli C., Lee H., et al. Scaffold Simplification Strategy Leads to a Novel Generation of Dual Human Immunodeficiency Virus and Enterovirus-A71 Entry Inhibitors. J. Med. Chem. 2020;63:349&#x2013;368. doi: 10.1021/acs.jmedchem.9b01737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.9b01737</ArticleId><ArticleId IdType="pubmed">31809045</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L., Lee H., Thibaut H.J., Lanko K., Rivero-Buceta E., Bator C., Martinez-Gualda B., Dallmeier K., Delang L., Leyssen P., et al. Viral Engagement with Host Receptors Blocked by a Novel Class of Tryptophan Dendrimers That Targets the 5-Fold-Axis of the Enterovirus&#x2014;A 71 Capsid. PLoS Pathog. 2019;15:e1007760. doi: 10.1371/journal.ppat.1007760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007760</ArticleId><ArticleId IdType="pmc">PMC6590834</ArticleId><ArticleId IdType="pubmed">31071193</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Rodriguez J., Albericio F., Lavilla R. Postsynthetic Modification of Peptides: Chemoselective C-Arylation of Tryptophan Residues. Chem.&#x2014;A Eur. J. 2010;16:1124&#x2013;1127. doi: 10.1002/chem.200902676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/chem.200902676</ArticleId><ArticleId IdType="pubmed">20013969</ArticleId></ArticleIdList></Reference><Reference><Citation>Preciado S., Mendive-Tapia L., Albericio F., Lavilla R. Synthesis of C-2 Arylated Tryptophan Amino Acids and Related Compounds through Palladium-Catalyzed C-H Activation. J. Org. Chem. 2013;78:8129&#x2013;8135. doi: 10.1021/jo400961x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jo400961x</ArticleId><ArticleId IdType="pubmed">23865986</ArticleId></ArticleIdList></Reference><Reference><Citation>Gowda D.C., Rajesh B., Gowda S. Ammonium Formate Catalytic Transfer Hydrogenation: A Convenient Method for Removal of Halogenated Benzyloxycarbonyl and Benzyl Protecting Groups in Peptide Synthesis. Indian J. Chem.&#x2014;Sect. B Org. Med. Chem. 2000;39:504&#x2013;508. doi: 10.1002/chin.200107166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/chin.200107166</ArticleId></ArticleIdList></Reference><Reference><Citation>Newkome G.R., Lin X. Symmetrical, Four-Directional, Poly(Ether-Amide) Cascade Polymers. Macromolecules. 1991;24:1443&#x2013;1444. doi: 10.1021/ma00006a042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ma00006a042</ArticleId></ArticleIdList></Reference><Reference><Citation>Potukuchi H.K., Bach T. Selective C-2 Alkylation of Tryptophan by a Pd(II)/Norbornene-Promoted C-H Activation Reaction. J. Org. Chem. 2013;78:12263&#x2013;12267. doi: 10.1021/jo402107m.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jo402107m</ArticleId><ArticleId IdType="pubmed">24237413</ArticleId></ArticleIdList></Reference><Reference><Citation>Balzarini J., Naesens L., Slachmuylders J., Niphuis H., Rosenberg I., Hol A., Schellekens H., Clercq E. De 9-(2-Phosphonylmethoxyethyl)Adenine (PMEA) Effectively Inhibits Retrovirus Replication in Vitro and Simian Immunodeficiency Virus Infection in Rhesus Monkeys. Aids. 1991;5:21&#x2013;28. doi: 10.1097/00002030-199101000-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002030-199101000-00003</ArticleId><ArticleId IdType="pubmed">2059358</ArticleId></ArticleIdList></Reference><Reference><Citation>Baba M., Pauwels R., Balzarini J., Arnout J., Desmyter J., De Clercq E. Mechanism of Inhibitory Effect of Dextran Sulfate and Heparin on Replication of Human Immunodeficiency Virus in Vitro. Proc. Natl. Acad. Sci. USA. 1988;85:6132&#x2013;6136. doi: 10.1073/pnas.85.16.6132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.85.16.6132</ArticleId><ArticleId IdType="pmc">PMC281919</ArticleId><ArticleId IdType="pubmed">2457906</ArticleId></ArticleIdList></Reference><Reference><Citation>Balzarini J., Van Laethem K., Daelemans D., Hatse S., Bugatti A., Rusnati M., Igarashi Y., Oki T., Schols D. Pradimicin A, a Carbohydrate-Binding Nonpeptidic Lead Compound for Treatment of Infections with Viruses with Highly Glycosylated Envelopes, Such as Human Immunodeficiency Virus. J. Virol. 2007;81:362&#x2013;373. doi: 10.1128/JVI.01404-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01404-06</ArticleId><ArticleId IdType="pmc">PMC1797273</ArticleId><ArticleId IdType="pubmed">17050611</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S., Yamashita Y., Li J., Hanagata N., Minowa T., Takemura T., Koike S. Scavenger Receptor B2 Is a Cellular Receptor for Enterovirus 71. Nat. Med. 2009;15:798&#x2013;801. doi: 10.1038/nm.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1992</ArticleId><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Tijsma A., Franco D., Tucker S., Hilgenfeld R., Froeyen M., Leyssen P., Neyts J. The Capsid Binder Vapendavir and the Novel Protease Inhibitor SG85 Inhibit Enterovirus 71 Replication. Antimicrob. Agents Chemother. 2014;58:6990&#x2013;6992. doi: 10.1128/AAC.03328-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.03328-14</ArticleId><ArticleId IdType="pmc">PMC4249361</ArticleId><ArticleId IdType="pubmed">25199773</ArticleId></ArticleIdList></Reference><Reference><Citation>Andries K., Dewindt B., Snoeks J., Willebrords R., Van Eemeren K., Stokbroekx R., Janssen P.A.J. In Vitro Activity of Pirodavir (R 77975), a Substituted Phenoxy- Pyridazinamine with Broad-Spectrum Antipicornaviral Activity. Antimicrob. Agents Chemother. 1992;36:100&#x2013;107. doi: 10.1128/AAC.36.1.100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.36.1.100</ArticleId><ArticleId IdType="pmc">PMC189235</ArticleId><ArticleId IdType="pubmed">1317142</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;-Mar&#xed; O., Mart&#xed;nez-Gualda B., de la Puente-Secades S., Mills A., Quesada E., Abdelnabi R., Sun L., Boonen A., Noppen S., Neyts J., et al. Double Arylation of the Indole Side Chain of Tri- And Tetrapodal Tryptophan Derivatives Renders Highly Potent HIV-1 and EV-A71 Entry Inhibitors. J. Med. Chem. 2021;64:10027&#x2013;10046. doi: 10.1021/acs.jmedchem.1c00315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.1c00315</ArticleId><ArticleId IdType="pmc">PMC8389807</ArticleId><ArticleId IdType="pubmed">34229438</ArticleId></ArticleIdList></Reference><Reference><Citation>Fasting C., Schalley C.A., Weber M., Seitz O., Hecht S., Koksch B., Dernedde J., Graf C., Knapp E., Haag R. Multivalency as a Chemical Organization and Action Principle Angewandte. Angew. Chem. Int. Ed. 2012;51:10472&#x2013;10498. doi: 10.1002/anie.201201114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.201201114</ArticleId><ArticleId IdType="pubmed">22952048</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K., Koike S. Cellular Receptors for Enterovirus A71. J. Biomed. Sci. 2020;27:23. doi: 10.1186/s12929-020-0615-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-020-0615-9</ArticleId><ArticleId IdType="pmc">PMC6954530</ArticleId><ArticleId IdType="pubmed">31924205</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo D., Yu X., Wang D., Li Z., Zhou Y., Xu G., Yuan B., Qin Y., Chen M. SLC35B2 Acts in a Dual Role in the Host Sulfation Required for EV71 Infection. J. Virol. 2022;96:e02042-21. doi: 10.1128/jvi.02042-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.02042-21</ArticleId><ArticleId IdType="pmc">PMC9093107</ArticleId><ArticleId IdType="pubmed">35420441</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeire K., Princen K., Hatse S., De Clercq E., Dey K., Bell T.W., Schols D. CADA, a Novel CD4-Targeted HIV Inhibitor, Is Synergistic with Various Anti-HIV Drugs in Vitro. Aids. 2004;18:2115&#x2013;2125. doi: 10.1097/00002030-200411050-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002030-200411050-00003</ArticleId><ArticleId IdType="pubmed">15577644</ArticleId></ArticleIdList></Reference><Reference><Citation>Pauwels R., Balzarini J., Baba M., Snoeck R., Schols D., Herdewijn P., Desmyter J., De Clercq E. Rapid and Automated Tetrazolium-Based Colorimetric Assay for the Detection of Anti-HIV Compounds. J. Virol. Methods. 1988;20:309&#x2013;321. doi: 10.1016/0166-0934(88)90134-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0166-0934(88)90134-6</ArticleId><ArticleId IdType="pubmed">2460479</ArticleId></ArticleIdList></Reference><Reference><Citation>DeLano W.L. The PyMOL Molecular Graphics System. Schr&#xf6;dinger, LLC; New York, NY, USA: 2013.</Citation></Reference><Reference><Citation>Walker R.C., Crowley M.F., Case D.A. The Implementation of a Fast and Accurate QM / MM Potential Method in Amber. J. Comput. Chem. 2007;29:1019&#x2013;1031. doi: 10.1002/jcc.20857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.20857</ArticleId><ArticleId IdType="pubmed">18072177</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmerling C. Ff 14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from Ff 99SB. J. Chem. Theory Comput. 2015;11:3696&#x2013;3713. doi: 10.1021/acs.jctc.5b00255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jctc.5b00255</ArticleId><ArticleId IdType="pmc">PMC4821407</ArticleId><ArticleId IdType="pubmed">26574453</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Wolf R.M., Caldwell J.W., Kollman P.A., Case D.A. Development and Testing of a General Amber Force Field. J. Comput. Chem. 2004;25:1157&#x2013;1174. doi: 10.1002/jcc.20035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.20035</ArticleId><ArticleId IdType="pubmed">15116359</ArticleId></ArticleIdList></Reference><Reference><Citation>Case D.A., Walker R.C., Cheatham T.E., Simmerling C., Roitberg A., Merz K.M., Luo R., Darden T. Amber 18. University of California; San Francisco, CA, USA: 2018.</Citation></Reference><Reference><Citation>Trott O., Olson A.J. AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading. J. Comput. Chem. 2009;31:455&#x2013;461. doi: 10.1002/jcc.21334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.21334</ArticleId><ArticleId IdType="pmc">PMC3041641</ArticleId><ArticleId IdType="pubmed">19499576</ArticleId></ArticleIdList></Reference><Reference><Citation>Explicit G., Particle S., Ewald M., Salomon-ferrer R., Goetz A.W., Poole D., Grand S.L., Walker R.C. Routine Microsecond Molecular Dynamics Simulations with Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald. J. Chem. Theory Comput. 2013;9:3878&#x2013;3888. doi: 10.1021/ct400314y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ct400314y</ArticleId><ArticleId IdType="pubmed">26592383</ArticleId></ArticleIdList></Reference><Reference><Citation>Pires D.E., Blundell T.L., Ascher D.B. pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures. J. Med. Chem. 2015;58:4066&#x2013;4072. doi: 10.1021/acs.jmedchem.5b00104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.5b00104</ArticleId><ArticleId IdType="pmc">PMC4434528</ArticleId><ArticleId IdType="pubmed">25860834</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>